| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| John Alexander Kelly | Chief Financial Officer | 2026-02-18 | 8,149 | $3.84 | $31.29kSell |
| Dario Scimeca | General Counsel and Secretary | 2026-02-18 | 4,925 | $3.84 | $18.91kSell |
| Michael Amoroso | President and CEO | 2026-02-18 | 20,559 | $3.84 | $78.95kSell |
| J. Jefferson Smith | Chief Research Officer | 2026-02-18 | 4,925 | $3.84 | $18.91kSell |
| Michael Amoroso | President and CEO | 2026-01-22 | 34,799 | $4.17 | $145.11kSell |
| Dario Scimeca | General Counsel and Secretary | 2026-01-21 | 8,854 | $4.03 | $35.68kSell |
| J. Jefferson Smith | Chief Research Officer | 2026-01-21 | 10,200 | $4.03 | $41.11kSell |
| John Alexander Kelly | Chief Financial Officer | 2026-01-21 | 15,213 | $4.03 | $61.31kSell |
| Stanley Frankel | Director | 2025-12-16 | 2,700 | $4.70 | $12.69kBuy |
| Geno J. Germano | Director | 2025-12-16 | 3,000 | $4.72 | $14.16kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Pharma Ag Novartis | 44.95% | 12,407,440 | $82.76M | Insider |
| Venbio Global Strategic Fund LP | 15.45% | 4,265,141 | $28.45M | Insider |
| Derek Jantz | 14.69% | 4,055,174 | $27.05M | Insider |
| Fmr LLC | 13.54% | 3,738,248 | $24.93M | Insider |
| Matthew R. Kane | 7.33% | 2,024,438 | $13.50M | Insider |
| Michael Amoroso | 0.88% | 243,392 | $1.62M | Insider |
| Tony Dung Ling Yao | 0.60% | 166,903 | $1.11M | Insider |
| Abid Ansari | 0.52% | 144,401 | $963.15k | Insider |
| J. Jefferson Smith | 0.47% | 129,857 | $866.15k | Insider |
| John Alexander Kelly | 0.46% | 125,883 | $839.64k | Insider |